Baseline plasma lipidome correlates with direct-acting antiviral therapy non-response for HCV in HIV-HCV coinfected patients

被引：0

作者：

Maras, Jaswinder ^{[1
]}

Bindal, Vasundhra ^{[1
]}

Tripathi, Gaurav ^{[1
]}

Yadav, Manisha ^{[1
]}

Sharma, Nupur ^{[1
]}

Mathew, Babu ^{[1
]}

Bhat, Sadam H. ^{[1
]}

Gupta, Abhishak ^{[1
]}

Sharma, Neha ^{[1
]}

Pandey, Sushmita ^{[1
]}

Gupta, Ekta ^{[2
]}

机构：

[1] Inst Liver & Biliary Sci, Dept Mol & Cellular Med, New Delhi, India

[2] Inst Liver & Biliary Sci, Dept Clin Virol, New Delhi, India

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI-247

引用

页码：S1033 / S1034

页数：2

共 50 条

[21] HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
Brochado-Kith, Oscar
Martinez, Isidoro
Berenguer, Juan
Gonzalez-Garcia, Juan
Salguero, Sergio
Sepulveda-Crespo, Daniel
Diez, Cristina
Hontanon, Victor
Ibanez-Samaniego, Luis
Perez-Latorre, Leire
Fernandez-Rodriguez, Amanda
angeles Jimenez-Sousa, Maria
Resino, Salvador
FRONTIERS IN IMMUNOLOGY, 2021, 12
[22] A revolution in HCV treatment with direct-acting antivirals: From non-response to eradication
Asselah, Tarik
JOURNAL OF HEPATOLOGY, 2012, 57 (02) : 455 - 457
[23] Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals
Naggie, Susanna
Sulkowski, Mark S.
GASTROENTEROLOGY, 2012, 142 (06) : 1324 - +
[24] Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis
Merchante, Nicolas
Rivero-Juarez, Antonio
Tellez, Francisco
Merino, Dolores
Rios-Villegas, Maria J.
Villalobos, Marina
Omar, Mohamed
Rincon, Pilar
Rivero, Antonio
Perez-Perez, Montserrat
Raffo, Miguel
Lopez-Montesinos, Inmaculada
Palacios, Rosario
Gomez-Vidal, Maria A.
Macias, Juan
Pineda, Juan A.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (09) : 2435 - 2443
[25] Baseline HCV RNA and rapid virological decay are the main predictors of sustained virological response in HIV-HCV coinfected patients
Martin-Carbonero, L.
Nunez, M.
Barreiro, P.
Romero, M.
Garcia-Samaniego, J.
Sola, J.
Berdun, M. A.
Hernandez-Burruezo, J. J.
Galindo, M. J.
MiralleS, C.
Ramos, B.
Soriano, V.
JOURNAL OF HEPATOLOGY, 2007, 46 : S233 - S233
[26] Aggressive daily interferon therapy in HIV-HCV coinfected patients
Bruno, R
Sacchi, P
Filice, C
Filice, G
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (04) : 372 - 373
[27] Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients
Macias, Juan
Tellez, Francisco
Rivero-Juarez, Antonio
Palacios, Rosario
Morano, Luis E.
Merino, Dolores
Collado, Antonio
Garcia-Fraile, Lucio
Omar, Mohamed
Pineda, Juan A.
Merchante, Nicolas
Mancebo, Maria
Rivero, Antonio
Marquez, Manuel
Romero, Josefa
de los Santos, Ignacio
Amparo Gomez-Vidal, Ma
JOURNAL OF VIRAL HEPATITIS, 2019, 26 (01) : 48 - 54
[28] Effects of Antiviral Therapy on Liver Histology, Hvpg and Liver Stiffness in HIV-HCV Coinfected Patients
Reiberger, Thomas
Ferlitsch, Arnulf
Payer, Berit A.
Sieghart, Wolfgang
Rieger, Armin
Peck-Radosavljevic, Markus
GASTROENTEROLOGY, 2010, 138 (05) : S829 - S829
[29] The risk of infections in HIV-HCV coinfected patients during antiviral therapy with pegIFN+RBV
Payer, B. A.
Reiberger, T.
Breitenecker, F.
Aichelburg, M. C.
Schuster, C.
Heil, P. M.
Scherzer, T. M.
Ferenci, P.
Rieger, A.
Peck-Radosavljevic, M.
JOURNAL OF INFECTION, 2012, 65 (02) : 142 - 149
[30] Low Utilization of Direct-Acting Antiviral Agents in a Large National Cohort of HIV and HCV Coinfected Medicare Patients in the United States: Implications for HCV Elimination
Du, Ping
Jung, Jeah
Kalidindi, Yamini
Farrow, Kevin
Riley, Thomas I. I. I. I. I. I.
Whitener, Cynthia
JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE, 2022, 28 (02): : 130 - 134

← 1 2 3 4 5 →